| Literature DB >> 23911411 |
Juliana Vitoriano-Souza1, Nádia das Dores Moreira, Daniel Menezes-Souza, Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Fernando Augusto Siqueira-Mathias, Jamille Mirelle de Oliveira Cardoso, Rodolfo Cordeiro Giunchetti, Renata Guerra de Sá, Rodrigo Corrêa-Oliveira, Cláudia Martins Carneiro, Alexandre Barbosa Reis.
Abstract
The complex interplay between cytokines and chemokines regulates innate and adaptive immune responses against pathogens; specifically, cytokine and chemokine expression drives activation of immune effector cells and their recruitment to tissue infection sites. Herein, we inoculated dogs with Leishmania braziliensis antigens plus saponin (the LBSap vaccine), as well as with the vaccine components, and then used real-time PCR to evaluate the kinetics of dermal expression of mRNAs of cytokines (IL-12, IFN-γ, TNF-α, IL-4, IL-13, TGF-β and IL-10) and chemokines (CCL2, CCL4, CCL5, CCL21 and CXCL8) 1, 12, 24 and 48 h after inoculation. We also evaluated the correlation between cytokine and chemokine expression and dermal cellularity. The LBSap vaccine induced high levels of IL-12 and IL-10 expression at 12 and 24 h, respectively. Furthermore, we observed positive correlations between IL-12 and IL-13 expression, IFN-γ and IL-13 expression, and IL-13 and TGF-β expression, suggesting that a mixed cytokine microenvironment developed after immunization with the vaccine. Inoculation with the saponin adjuvant alone induced a chemokine and cytokine expression profile similar to that observed in the LBSap group. CCL4 and CXCL8 chemokine expression was up regulated by the LBSap vaccine. CCL5 expression was initially highest in the LBSap group, but at 48 h, expression was highest in the LB group. Information about the kinetics of the immune response to this vaccine gained using this dog model will help to elucidate the mechanisms of and factors involved in a protective response against Leishmania infection and will aid in establishing rational approaches for the development of vaccines against canine visceral leishmaniasis.Entities:
Keywords: Adjuvants; Canine visceral leishmaniasis; Chemokines; Cytokines; Real-time PCR; Saponin; Vaccine
Mesh:
Substances:
Year: 2013 PMID: 23911411 PMCID: PMC7112513 DOI: 10.1016/j.molimm.2013.05.231
Source DB: PubMed Journal: Mol Immunol ISSN: 0161-5890 Impact factor: 4.407
Sequences of forward (F) and reverse (R) primers used for real-time PCR quantification of mRNA expression in skin biopsies of immunized dogs.
| Gene | Primer sequence (5′–3′) | Product length (bp) | Reaction efficiency (%) | GenBank accession no. | |
|---|---|---|---|---|---|
| GAPDH | |||||
| F | TTCCACGGCACAGTCAAG | 115 | 99.1 | 0.996 | |
| R | ACTCAGCACCAGCATCAC | ||||
| IL-12p40 | |||||
| F | CAGCAGAGAGGGTCAGAGTGG | 109 | 96.5 | 0.989 | |
| R | ACGACCTCGATGGGTAGGC | ||||
| IFN-γ | |||||
| F | TCAACCCCTTCTCGCCACT | 113 | 95.4 | 0.967 | |
| R | GCTGCCTACTTGGTCCCTGA | ||||
| TNF-α | |||||
| F | CGTCCATTCTTGCCCAAAC | 94 | 97.2 | 0.983 | |
| R | AGCCCTGAGCCCTTAATTC | ||||
| IL-4 | |||||
| F | CACCTCCCAACTGATTCCAA | 123 | 96.9 | 0.991 | |
| R | CTCGCTGTGAGGATGTTCAA | ||||
| IL-13 | |||||
| F | CCTCCTCAGAGCAAAGTG | 148 | 96.7 | 0.973 | |
| R | CCCAGCACAAACAAAGAC | ||||
| IL-10 | |||||
| F | AGAACCACGACCCAGACATC | 129 | 97.1 | 0.993 | |
| R | CCACCGCCTTGCTCTTATTC | ||||
| TGF-β1 | |||||
| F | AGGATCTGGGCTGGAAGTG | 134 | 95.1 | 0.981 | |
| R | CGGGTTGTGCTGGTTGTA | ||||
| CCL2 | |||||
| F | CCTGCTGCTATACACTCA | 91 | 96.3 | 0.979 | |
| R | GCTTCTTTGGGACACTTG | ||||
| CCL4 | |||||
| F | TCCTACTGCCTGCTGCTT | 76 | 95.9 | 0.981 | |
| R | GCTGGTCTCAAAGTAATCTGC | ||||
| CCL5 | |||||
| F | TTCTACACCAGCAGCAAG | 136 | 98.7 | 0.991 | |
| R | TTCTACACCAGCAGCAAG | ||||
| CCL21 | |||||
| F | AGTCTGGCAAGAAGGGAAAG | 60 | 96.7 | 0.972 | |
| R | GGGTCTGTGGCTGTTCAGT | ||||
| CXCL8 | |||||
| F | ACACTCCACACCTTTCCAT | 116 | 98.7 | 0.977 | |
| R | GGCACACCTCATTTCCATTG | ||||
Fig. 1Relative expression of mRNAs of type I (IL-12, IFN-γ and TNF-α), type II (IL-4 and IL-13) and immunoregulatory (IL-10 and TGF-β) cytokines in the dermis of dogs 1, 12, 24 and 48 h after inoculation with L. braziliensis antigens (LB group; ), saponin (Sap group; ) or L. braziliensis antigens plus saponin (LBSap group; ■). Significant difference (p < 0.05) compared with Sap and LBSap are indicated by the letter “b”.
Fig. 2Correlations between relative expression of (A) type I and II cytokine mRNAs and (B) type II and immunoregulatory cytokine mRNAs in the dermis of dogs inoculated with L. braziliensis antigens (LB group; ), saponin (Sap group; ) or L. braziliensis antigens plus saponin (LBSap group; ●). Pearson's correlation indexes (r) and p-values are shown on the graphs.
Fig. 3Relative expression of mRNA of chemokines CCL2, CCL4, CCL5, CCL21 and CXCL8 in the dermis of dogs 1, 12, 24 and 48 h after inoculation with L. braziliensis antigens (LB group; ), saponin (Sap group; ) or L. braziliensis antigens plus saponin (LBSap group; ■). Significant differences (p < 0.05) compared with LB, Sap and LBSap are indicated by the letters “a,” “b” and “c,” respectively.
Fig. 4Correlations between relative expression of cytokine and chemokine mRNAs and percentages of macrophages and neutrophils in the outer and inner dermis of dogs after inoculation with L. braziliensis antigens (LB group; ), saponin (Sap group; ) or L. braziliensis antigens plus saponin (LBSap group; ●). Pearson's correlation indexes (r) and p-values are shown on the graphs.